Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo

Autor: Hugo Kavunga-Membo, Deborah Watson-Jones, Kambale Kasonia, Tansy Edwards, Anton Camacho, Grace Mambula, Darius Tetsa-Tata, Edward Man-Lik Choi, Soumah Aboubacar, Hannah Brindle, Chrissy Roberts, Daniela Manno, Benjamin Faguer, Zephyrin Mossoko, Pierre Mukadi, Michel Kakule, Benith Balingene, Esther Kaningu Mapendo, Rockyath Makarimi, Oumar Toure, Paul Campbell, Mathilde Mousset, Robert Nsaibirni, Ibrahim Seyni Ama, Kikongo Kambale Janvier, Babajide Keshinro, Badara Cissé, Mateus Kambale Sahani, John Johnson, Nicholas Connor, Shelley Lees, Nathalie Imbault, Cynthia Robinson, Rebecca F. Grais, Daniel G. Bausch, Jean Jacques Muyembe-Tamfum

Publikováno v: Vaccines, Vol 12, Iss 8, p 825 (2024)

During the 2018–2020 Ebola virus disease (EVD) outbreak, residents in Goma, Democratic Republic of the Congo, were offered a two-dose prophylactic EVD vaccine. This was the first study to evaluate the safety of this vaccine in pregnant women. Adult

Externí odkaz: https://doaj.org/article/446d4c0a94ee4c948ee38451ecc7be8c

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Autor: Alexandra Calmy, Tamara Tovar Sanchez, Charles Kouanfack, Mireille Mpoudi-Etame, Sandrine Leroy, Ségolène Perrineau, Martial Lantche Wandji, Darius Tetsa Tata, Pierette Omgba Bassega, Thérèse Abong Bwenda, Marie Varloteaux, Marcel Tongo, Eitel Mpoudi-Ngolé, Alice Montoyo, Noémie Mercier, Vincent LeMoing, Martine Peeters, Jacques Reynes, Eric Delaporte, A Calmy, T Tovar Sanchez, C Kouanfack, M Mpoudi-Etame, S Leroy, S Perrineau, M Lantche-Wandji, D Tetsa-Tata, P Omgba-Bassega, T Abong-Bwenda, M Varloteaux, M Tongo, E Mpoudi-Ngolé, A Montoyo, N Mercier, V LeMoing, M Peeters, J Reynes, E Delaporte, A Ayouba, A Agholeng, C Butel, A Cournil, S Eymard-Duvernay, B Granouillac, S Izard, A Lacroix, L Serrano, N Vidal, PJ Fouda, R Mougnoutou, J Olinga, V Omgba, SC Tchokonte-Ngandé, B Ymele, CD Epoupa-Mpacko, M Fotso, R Moukoko, T Nké, A Akamba, S Lekelem, SB Tongo-Fotack, S Ngono, M Tanga, E Ebong, G Edoul-Mbesse, L Ciaffi, S Koulla-Shiro, G Manirakiza, ED Mimbé, S Boyer, M Bousmah, G Maradan, ML Nishimwe, B Spire, MP Lê, G Peytavin, A Diallo, I Fournier, C Rekacewicz, C Perez Casas

Publikováno v: The Lancet HIV
The Lancet HIV, 2020, 7 (10), pp.e677-e687. ⟨10.1016/S2352-3018(20)30238-1⟩

International audience; Background: Updated WHO guidelines recommend a dolutegravir-based regimen as the preferred first-line treatment for HIV infection and low-dose efavirenz (400 mg) as an alternative. We aimed to report the non-inferior efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e04f3e8044bec57d70cb397c548401b0
https://hal.umontpellier.fr/hal-03337700

Monitoring the progress and impact of a multicountry, interdisciplinary research project on childhood stunting: the UKRI GCRF Action Against Stunting Hub MEL protocol

Autor: Bharati Kulkarni, Babacar Faye, Little Flower Augustine, Santosh Kumar Banjara, Claire Heffernan, Umi Fahmida, Min Kyaw Htet, Arienta R P Sudibya, Modou Lamin Jobarteh, Nur L Zahra, Assana Diop, Darius Tetsa Tata, Hugh Sharma Waddington, Marie K Harder, Fassiatou Tairou, Dinesh Yadav D M, Rose Ndulu Ndolo, Munikumar Manne, Camara Fatou Ndiaye Diop, Francis Naab, Chelsey Victoria Knott

Publikováno v: BMJ Paediatrics Open, Vol 8, Iss Suppl 1 (2024)

Externí odkaz: https://doaj.org/article/053adbaf1c2d474fa6e9f8049979914e